ArticleJournal of clinical medicine2023

Survival and Toxicities of Metastatic Colorectal Cancer Patients Treated with Regorafenib before TAS-102 or Vice Versa: A Mono-Institutional Real-Practice Study.

Alessandro Ottaiano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.